Stent thrombosis redux - The FDA perspective

被引：210

作者：

Farb, Andrew ^{[1
]}

Boam, Ashley B. ^{[1
]}

机构：

[1] US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA

来源：

关键词：

D O I：

10.1056/NEJMp068304

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：984 / 987

页数：4

共 5 条

[1]

American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021

[2]

CAMENZIND E, 2006, WORLD C CARD 2006 BA

Eisenstein, Eric L. ;

Anstrom, Kevin J. ;

Kong, David F. ;

Shaw, Linda K. ;

Tuttle, Robert H. ;

Mark, Daniel B. ;

Kramer, Judith M. ;

Harrington, Robert A. ;

Matchar, David B. ;

Kandzari, David E. ;

Peterson, Eric D. ;

Schulman, Kevin A. ;

Califf, Robert M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02) :159-168

[4] Problems with drug-eluting coronary stents - The FDA perspective [J].

Muni, NI ;

Gross, TP .

[5]

Wenaweser P., 2006, WORLD C CARD 2006 BA